Counter UAS Technology Europe 2024: Echodyne to Address Key C-UAS Conference Amidst Rapid Expansion into European Market
As the proliferation of drones and UAS technologies continues within the region and Echodyne invests in growing its European team, it leads a discussion at the major... Read more.
Siemens Commits to Full Digitization in Guarantee Management With Digital Vault Services
MUNICH–(BUSINESS WIRE)–#DIgitalVaultSevices–Digital Vault Services: Siemens chooses Digital Vault Services (DVS) for guarantee digitization. Collaboration... Read more.
Juniper Research: Digital Money Transfer Market: Huawei and Visa Revealed as Leaders in New Competitor Leaderboard
Total Money Transfer & Remittances Market to Exceed $6.5tn in Transactions by 2028 Globally BASINGSTOKE, England–(BUSINESS WIRE)–#combankdigitalmoneytransfer–A... Read more.
Pacific Prime Affirmed as the Top Individual Producer of Allianz for Four Consecutive Years
DUBAI, United Arab Emirates–(BUSINESS WIRE)–International insurance brokerage Pacific Prime was awarded the Top Individual Producer Award 2024 by Allianz.... Read more.
Japanese Investors Partner With I Squared Capital on US$370 Million Strategic Investment in Natural Gas Infrastructure to Accelerate the Energy Transition in India
– Japanese investors to take a minority stake in a Singapore-based holding company with investments in companies developing city gas distribution networks... Read more.
MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event
Positive efficacy and safety results in 140 patients treated with MaaT013 in acute graft-versus-host disease (aGvHD) as part of the MaaT Pharma Early Access Program... Read more.
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study
– Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse... Read more.
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) will hold... Read more.
Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
Partner Sanofi advances SAR443579 / IPH6101, ANKET® platform lead asset, a trifunctional anti-CD123 NKp46xCD16 NK cell engager, to Phase 2 dose expansion in blood... Read more.
Proposed Changes to BenevolentAI’s Board Composition
LONDON–(BUSINESS WIRE)–Regulatory News: BenevolentAI (or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate... Read more.